HAPLO-IDENTICAL HCT

Clinical trials for HAPLO-IDENTICAL HCT explained in plain language.

Never miss a new study

Get alerted when new HAPLO-IDENTICAL HCT trials appear

Sign up with your email to follow new studies for HAPLO-IDENTICAL HCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Engineered donor cells aim to shield transplant patients from dangerous viruses

Disease control Not yet recruiting

This trial tests whether giving patients a special type of donor immune cell, called CD45RA-depleted DLI, can prevent serious viral infections after a stem cell transplant. The study includes 30 high-risk patients who have received a transplant for blood cancer. Researchers will …

Matched conditions: HAPLO-IDENTICAL HCT

Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

HAPLO-IDENTICAL HCT

Get alerted when new HAPLO-IDENTICAL HCT trials appear

Engineered donor cells aim to shield transplant patients from dangerous viruses